<DOC>
	<DOCNO>NCT00579046</DOCNO>
	<brief_summary>The purpose study determine impact erythropoietin treatment anemia exercise capacity patient chronic obstructive pulmonary disease ( COPD ) .</brief_summary>
	<brief_title>Study Erythropoietin Treat Anemia Complicating Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>The development anemia patient chronic obstructive pulmonary disease ( COPD ) take predictor increase morbidity mortality . Preliminary data patient investigated department indicate negative correlation anemia severity 6-minute walking distance . Our work hypothesis hemoglobin level correction erythropoietin therapy improve effort capacity patient COPD anemia . Our objective conduct pilot study efficacy darbepoetin alfa . The study include 15 patient COPD recruit three pulmonology center base two selection criterion : COPD stage II III IV accord GOLD criterion hemoglobin level le 12 g/dL . Effort capacity evaluate chiefly perform 6-minute walk test measure VO2 maximum exertion bicycle ergometer increase load . Darbepoetin alfa give 2 month . If hemoglobin increase le 1 g/dL 1 month , dosage increase 25 % . Effort parameter measure baseline 1 2 month treatment . Among secondary objective , evaluate functional ergospirometric parameter laboratory test inflammation . Total study duration exceed 18 month .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Male female age 4075 year Diagnosis moderate severe COPD ( stage II , III IV accord GOLD criterion ) A ratio postbronchodilator FEV1 force vital capacity ( FVC ) &lt; 70 % A FEV1 &lt; 80 % predict value Hemoglobin level le 12 g/dL Peak VO2 le 80 % predict value 6min walk test distance le 500 meter Hemorrhagic anemia Iron deficiency anemia ( ferritin &lt; 30 ng/ml ) Folate Vitamin B12 deficiency anemia Myelodysplastic Syndrome Chronic disease associate anemia : renal insufficiency , inflammatory disease , neoplastic disease , leave ventricular insufficiency ( ejection fraction &lt; 40 % ) Chronic disease likely interfere dyspnea exercise test ( cardiac insufficiency , neurologic disease , claudication ) Acute exacerbation COPD within last 4 week History thromboembolic disease Contraindications cardiopulmonary exercise test Contraindications darbepoetin alfa treatment : uncontrolled arterial hypertension hypersensitivity reaction darbepoetin alfa Pregnancy breastfeeding ( woman reproductive potential use adequate birth control measure whole duration study treatment )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Chronic obstructive Pulmonary Disease</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>6-minute walk test</keyword>
</DOC>